Skip to content

Deferred Taxes at other companies

Neogen logo
NeogenNEOG
$269.2M-10.6%
Veracyte logo
VeracyteVCYT
$636K-48.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Zoetis logo
ZoetisZTS
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's deferred taxes?
Idexx Laboratories (IDXX) reported deferred taxes of $44.6M in Q1 2026.
How has Idexx Laboratories's deferred taxes changed year-over-year?
Idexx Laboratories's deferred taxes increased by 449.9% year-over-year, from $8.11M to $44.6M.
What is the long-term trend for Idexx Laboratories's deferred taxes?
Over 5 years (2020 to 2025), Idexx Laboratories's deferred taxes has grown at a 22.2% compound annual growth rate (CAGR), from $11.71M to $31.87M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.